![David Lennon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Lennon
Chief Executive Officer at
WHITEHAWK THERAPEUTICS, INC.
Net worth: 3 M $ as of 2026-05-30
Profile
Currently, David Lennon is President, Chief Executive Officer & Director at Whitehawk Therapeutics, Inc. since 2023 and Vice Chairman at Alliance for Regenerative Medicine since 2023.
Formerly, Dr. Lennon was Chief Executive Officer & Director at Satellite Biosciences, Inc. from 2021 to 2023, President at Novartis Gene Therapies, Inc. from 2020 to 2021, Managing Director & GM-Oncology Business at Novartis Pharma KK, President at Novartis AG, and Associate Principal at McKinsey & Co., Inc. Education includes a doctorate from Weill Cornell Medical College and an undergraduate degree from Columbia College (New York).
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-05-13 | 569,643 ( 1.21% ) | 3 M $ | 2026-05-30 |
David Lennon active positions
| Companies | Position | Start |
|---|---|---|
| WHITEHAWK THERAPEUTICS, INC. | Chief Executive Officer | 2023-10-01 |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Director/Board Member | 2021-10-20 |
Former positions of David Lennon
| Companies | Position | End |
|---|---|---|
Satellite Biosciences, Inc.
 Satellite Biosciences, Inc. BiotechnologyHealth Technology Provides shelf liver therapy services | Chief Executive Officer | 2023-08-31 |
| AVEXIS INC | President | 2021-06-30 |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Corporate Officer/Principal | - |
| NOVARTIS AG | President | - |
Novartis Pharma KK
 Novartis Pharma KK Pharmaceuticals: MajorHealth Technology Develops, imports, produces and markets pharmaceutical products | Director/Board Member | - |
Training of David Lennon
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
4
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Weill Cornell Medical College
 Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharma KK
Novartis Pharma KK Pharmaceuticals: MajorHealth Technology Develops, imports, produces and markets pharmaceutical products | Health Technology |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
Columbia College (New York)
 Columbia College (New York) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Operates as a clinical-stage gene therapy company | Health Technology |
Satellite Biosciences, Inc.
Satellite Biosciences, Inc. BiotechnologyHealth Technology Provides shelf liver therapy services | Health Technology |
Aadi Bioscience, Inc.
 Aadi Bioscience, Inc. BiotechnologyHealth Technology Develops mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases | Health Technology |
- Stock Market
- Insiders
- David Lennon
